06 maggio 2021 | 07.14
LETTURA: 3 minuti
Patient Wounds Documented by MolecuLight i:X Device Now Integrated with EHR Systems Through Net Health's Tissue Analytics Platform
PITTSBURGH and TORONTO, May 6, 2021 /PRNewswire/ -- MolecuLight, the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announced today that the company has partnered with Tissue Analytics, a Net Health company that provides software solutions for the wound care industry. The purpose of the partnership is to integrate the MolecuLight platform with Net Health's Tissue Analytics application programming interface (API) program.
For clinical sites using both MolecuLight and Tissue Analytics, wound care clinicians can now upload standard and fluorescence images captured with the MolecuLight i:X device to the patient's record in the EHR (electronic health record) platform. The integrated platforms allow clinicians to optimize their workflow and document their patients' wounds digitally.